Daniel Gonzalez

, Jr.

Overview

Daniel Gonzalez Jr. is an associate* with McDonnell Boehnen Hulbert & Berghoff LLP. Mr. Gonzalez concentrates his practice on intellectual property law matters, including patent prosecution in the chemical and biotechnology practice areas.

Prior to joining MBHB, Mr. Gonzalez worked alongside electrophysiologists and clinical field engineers conducting clinical research studies for medical device manufacturers and pharmaceutical companies.

During law school, Mr. Gonzalez served as the Editor-in-Chief on Board XXI of The Houston Journal of Health Law & Policy. He also served as a teaching assistant for both Contracts and Criminal Law, after receiving the highest grade in his section for Contracts. He gained practical knowledge while working with faculty co-founding a new course, IP for Tech-Startups.

Mr. Gonzalez conducted oral arguments regarding a motion for partial summary judgment before a federal judge in the Southern District of Texas.

*Not yet admitted to practice in Illinois

Education
  • J.D., The University of Houston Law Center
  • B.S., The University of Texas at Dallas,

    Chemistry & Molecular Biology

Memberships
  • Hispanic National Bar Association

Published Articles

John Conour & Daniel Gonzalez, Why Method of Treatment Patents for Repurposed Drugs Are Worth the Investment, MBHB Snippets (Oct. 1, 2020)

Daniel Gonzalez, Comment, The Use of Ultra-Long Patent Terms to Incentivize the Development of Novel Antibiotics, 21 HOUS. J. HEALTH & POL’Y (forthcoming Oct. 2021)